Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zynerba Pharmaceuticals, Inc. | Chief Legal Officer | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
Zynerba Pharmaceuticals, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZYNE | Zynerba Pharmaceuticals, Inc. | Oct 10, 2023 | 4 | $0 | 4 | Oct 11, 2023 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Feb 15, 2023 | 1 | -$1.72K | 4 | Feb 17, 2023 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Feb 7, 2023 | 2 | -$3.26K | 4 | Feb 9, 2023 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jan 31, 2023 | 2 | -$3.48K | 4 | Feb 2, 2023 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jan 24, 2023 | 1 | $0 | 4 | Jan 25, 2023 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Feb 14, 2022 | 2 | $0 | 4 | Feb 15, 2022 | Chief Legal Officer |
ZYNE | Zynerba Pharmaceuticals, Inc. | Feb 14, 2022 | 0 | $0 | 3 | Feb 15, 2022 | Chief Legal Officer |